Caruso, Anthony (febit 200705– VP Informatics before Lion) |
n. a. |
Hummingbird Diagnostics GmbH |
Germany |
Carvell, John (Aber Instruments 201302 Sales + Marketing Director) |
Sales Manager / Marketing Manager |
Aber Instruments (Group) |
United Kingdom (GB) |
Casari, Georg (CeMM 201211 Director + Haplogen 201211 CEO + founder before Oridis Biomed + Cellzome + Lion Bioscience) |
Managing Director |
Haplogen Bioscience GmbH |
Austria |
Casarosa, Paola (Boehringer 202401– Managing Director Innovation Unit before Global Head Therapeutic Areas joined 2007) |
Business Development Manager / Strategy Manager |
Boehringer Ingelheim Innovation Unit |
Germany |
Cascella, Chris (Thermo Fisher 202109 General Manager Inorganic MS, Chromatography + MS) |
General Manager (management) |
Thermo Fisher (Group) |
United States (USA) |
Cascella, Robert (Philips SVP Diagnosis + Treatment business before Hologic CEO) |
Chief Executive Officer (CEO) |
Philips (Group) |
Netherlands |
Casebourne, Charlotte (Theolytics 202107 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Theolytics Ltd. |
United Kingdom (GB) |
Casel, Hans-Peter (Sartorius 201012 Managing Director of Sartorius Stedim Systems GmbH) |
Managing Director |
Sartorius (Group) |
Germany |
Casilag, Fiordiligie (Pepperprint 202206 Head of Marketing + Science Communications) |
Sales Manager / Marketing Manager |
Pepperprint GmbH |
Germany |
Casper, Marc N. (Thermo Fisher 200910– CEO before 200805– COO joined Thermo 12/01 before Kendro CEO before Dade Behring) |
Chief Executive Officer (CEO) |
Thermo Fisher (Group) |
United States (USA) |
Caspi, Guy (Deep Instinct 202104 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Deep Instinct (Group) |
United States (USA) |
Cassani, Danilo (Takeda 201502 Area Head Near East + Middle East + Africa) |
Regional manager |
Takeda (Group) |
Japan |
Castanheira, Mariana (JMI Laboratories 201206 Research Scientist) |
Researcher (industry) |
JMI Laboratories (JMI Labs) |
United States (USA) |
Castiglia, Evan (Thuja Capital 202406 Partner) |
Partner (venture partner) |
Thuja Capital (Group) |
Netherlands |
Castorina, Maurizio (Zambon 201511 CEO) |
Chief Executive Officer (CEO) |
Zambon (Group) |
Italy |
Castrillo, José Luís (Genetadi Biotech 201507 CEO) |
Chief Executive Officer (CEO) |
Genetadi Biotech S.L |
Spain (España) |
Castro Gutierrez, Juan P. (ThinqLab 202311 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Holtzbrinck (Group) |
United Kingdom (GB) |
Caswell, Mark (Rentschler 202207– VP Site Head for US Facility before Lonza Biologics + Sanofi Genzyme) |
President/Director/Head Business Group/Unit/Division |
Rentschler (Group) |
United States (USA) |
Catenhusen, Wolf Michael |
n. a. |
Germany (govt) |
Germany |
Catsicas, Stefan (SkyViews Life Science 202012 Managing Partner) |
Managing Partner (investment firm) |
SkyViews Life Science S.A. |
Switzerland |
Cattaneo, Roberto (Bracco 201710 Media Relations at Bracco Imaging SpA) |
Public Relations Manager / Investor Relations Manager |
Bracco (Group) |
Italy |
Caulder, Jerry (Finistere Ventures 201502 Chairman) |
Venture Partner |
Finistere Partners LLC (Finistere Ventures) |
United States (USA) |
Cautreels, Werner (Selecta Biosciences 2012 CEO before CEO of Solvay Pharmaceuticals before Sanofi + Sterling-Winthrop) |
Chief Executive Officer (CEO) |
Selecta Biosciences (Group) |
United States (USA) |
Cavalleri, Andrea (Max Planck 201211– Founding Director of MPI for Structure and Dynamics of Matter) |
President/Director/Head Business Group/Unit/Division |
Max Planck Society for the Advancement of Science |
Germany |
Cavalli, Fabio (MondoBiotech 200901 CEO) |
Chief Executive Officer (CEO) |
Relief Therapeutics (Group) |
Switzerland |
Cavanagh, Shawn (Lonza Bioscience 200807 President) |
n. a. |
Lonza (Group) |
Switzerland |
Cavdar, Avni (Zivak Technologies 201310 President) |
President/Director/Head Business Group/Unit/Division |
Zivak Technologies (TR) |
Turkey |
Cavey, Andrew (ITM Isotope Technologies Munich 202409– CEO before BMS + Novartis) |
Chief Executive Officer (CEO) |
ITM (Group) |
Germany |
Cawthorn, Robert (Actelion –201109 existent Chairman of Board Directors TO LEAVE BOARD in 2012) |
Board member, non-executive |
Johnson & Johnson (JnJ) (Group) |
Switzerland |
Cayli, Aziz (Cellca GmbH 201201 Member of Shareholder Board before Managing Director ) |
Board member, non-executive |
Sartorius (Group) |
Germany |
Caßing, Anke (High-Tech Gründerfonds 202001) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
Ceelen, Liesbeth (BioLizard 202401 CEO) |
Chief Executive Officer (CEO) |
BioLizard (Group) |
Belgium |
Ceh, Borut (Labena 201506 CEO) |
Chief Executive Officer (CEO) |
Labena d.o.o. |
Slovenia |
Cerff, R. |
n. a. |
Technical University Braunschweig (TU Braunschweig) |
Germany |
Cevc, Gregor (IDEA AG –200710–201002 CEO resigned 2/10) |
Chief Executive Officer (CEO) |
IDEA AG |
Germany |
Cezanne, Andreas (Merck (DE) 202101 Head of Corporate Media Relations) |
Public Relations Manager / Investor Relations Manager |
Merck (DE) (Group) |
Germany |
Chabria, Mamta (Tandem Therapeutics 202403 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Tandem Therapeutics (CH) |
Switzerland |
Chagnon, Antoine (Lallemand 202311 CEO) |
President/Director/Head Business Group/Unit/Division |
Lallemand (Group) |
Canada |
Chambers, Michael (Aldevron 201805 CEO) |
Chief Financial Officer (CFO) |
Aldevron (Group) |
United States (USA) |
Chambon, Benjamin (Alira Health 202004 Chief Commercial Officer + Co-Founder) |
Chief Commercial Officer (CCO) |
Alira Health (CMC Consulting Boston) (Group) |
United States (USA) |
Chambré, Peter (Cambridge Antibody 200204– CEO before Celera Genomics COO before Bespak CEO) |
Chief Executive Officer (CEO) |
AstraZeneca (Group) |
United Kingdom (GB) |
Chan, Hing Kin (ProBioGen 200411) |
n. a. |
Minapharm (Group) |
Germany |
Chapman, Paul (Quanterix 201207– CEO before EMD Millipore + Roche) |
Chief Executive Officer (CEO) |
Quanterix (Group) |
United States (USA) |
Charles, Susan (Sue) (Instinctif 201611 Managing Partner Life Sciences before College Group + Northbank + HCC De Facto) |
Public Relations Manager / Investor Relations Manager |
Instinctif Partners (Group) |
United Kingdom (GB) |
Charlon, Vincent (Anergis 201103 CEO) |
Chief Executive Officer (CEO) |
Anergis S.A. |
Switzerland |
Charpentier, Emmanuelle (Helmholtz 201412 Professor at HZI) |
Professor |
Max Planck Society for the Advancement of Science |
Germany |
Chasseloup de Chatillon, Jean-Baptiste (Sanofi 201810– CFO joined 9/18 before PSA Group) |
Chief Financial Officer (CFO) |
Sanofi (Group) [since May 2011] |
France |
Chatterjee, Amit (Sartorius 200910 Managing Director Sartorius India) |
Managing Director |
Sartorius (Group) |
India |
Chatziathanasiou, Mathäos (MZ-Analysentechnik 201402 Managing Director) |
Managing Director |
MZ-Analysentechnik GmbH |
Germany |
Chaud, Bernard (Global Bioenergies 201702 Head of Industrial Strategy) |
Business Development Manager / Strategy Manager |
Global Bioenergies (Group) |
France |
Chaurushiya, Mira (5AM Ventures 202111 Partner) |
Partner (venture partner) |
5AM Ventures (US) |
United States (USA) |
Chaya, Dina (OrbiMed 202407 Partner before Onega Funds 202109) |
Partner (venture partner) |
OrbiMed (Group) |
United Kingdom (GB) |
Cheek, Julia (EverlyWell 201907 CEO + Founder) |
Chief Executive Officer (CEO) |
EverlyWell Inc. |
United States (USA) |
Chemnitz, Jan (Provirex 201911– Managing Director) |
Managing Director |
Provirex Genome Editing Therapies GmbH |
Germany |
Chen, Anna (Frazier Life Sciences 202411 Principal) |
Principal (venture capital) |
OrbiMed (Group) |
United States (USA) |
Chen, Benjamin (Immune Targeting Systems Ltd 201501 CEO) |
Chief Executive Officer (CEO) |
Altimmune (Group) |
United Kingdom (GB) |
Chen, Bihua (Cormorant Asset Management 201605 CEO) |
Chief Executive Officer (CEO) |
Cormorant Asset Management LP (LLC?) |
United States (USA) |
Chen, Elbert (Cytena 201907 CFO of Cytena Bioprocess Solutions Co Ltd) |
Chief Financial Officer (CFO) |
Bico (Group) |
Taiwan |
Chen, Henry (Delos Capital 2014– Managing Partner + Co-Founder) |
n. a. |
Delos Capital (Delos Advisors Ltd.) |
China |
Chen, Irene (DKSH 201804 Group Communications Manager of Business Unit Technology) |
Public Relations Manager / Investor Relations Manager |
DKSH (Group) |
Switzerland |
Chen, Shuaitong (Lily) (Triastek 202407 Public Relations) |
Public Relations Manager / Investor Relations Manager |
Triastek (Group) |
China |
Chen, Shuqi (IQuum 201404 CEO + Co-founder) |
Chief Executive Officer (CEO) |
Roche (Group) |
United States (USA) |
Chen, Yu (LePure Biotech 202408 CFO) |
Chief Financial Officer (CFO) |
LePure Biotech (Group) |
China |
Chen, Zhisheng (Chris) (WuXi Pharmatech 201812 CEO of WuXi Biologics) |
Chief Executive Officer (CEO) |
WuXi PharmaTech (Group) |
China |
Cheng, Jing (CapitalBio 200504 CEO + CTO) |
Chief Executive Officer (CEO) |
CapitalBio (Group) |
China |
Cheng, Senping (Triastek 202407 CEO + Founder) |
Chief Executive Officer (CEO) |
Triastek (Group) |
China |
Cheng, Yong-Sheng (PixelBiotech GmbH 201904– Managing Director + Co-Founder) |
Managing Director |
PixelBiotech GmbH |
Germany |
Cheng, Ziqiang (Zack) (Zion Pharma 202305 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Zion Pharma Ltd. (CN) |
China |
Chennaoui, Daniel (AllyWell 202412 Managing Director) |
Managing Director |
AllyWell GmbH (AllyTime) |
Germany |
Cherkasov, Dmitry (GenoVoxx 200502) |
n. a. |
GenoVoxx GmbH |
Germany |
Cheruvu, Pavan (Roivant 201806 CEO of Axovant Sciences) |
Chief Executive Officer (CEO) |
Sio Gene Therapies Inc. (Nasdaq: SIOX) |
United States (USA) |
Cheung, Tracy (Consilium Strategic Communciations 202205– Partner before Compass Pathways + Amersham + GE Healthcare) |
Public Relations Manager / Investor Relations Manager |
ICR (Group) |
United Kingdom (GB) |
Chevalier, Grégoire (Atopia Therapeutics 202405– CEO before Enterome) |
Chief Executive Officer (CEO) |
Atopia Therapeutics SA |
Switzerland |
Chhaya, Mohit (BellaSeno 202007 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
BellaSeno GmbH |
Germany |
Chiam, Maria (Go To Market Consulting Inc 201309 Founder) |
Company Founder |
Go To Market Consulting Inc. |
United States (USA) |
Chicca, Andrea (Synendos Therapeutics 202011 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Synendos Therapeutics AG |
Switzerland |
Chickosky, John (Natrix Separations 201708 CEO) |
Chief Executive Officer (CEO) |
Merck (DE) (Group) |
Canada |
Chiesi, Antonio (HansaBioMed Life Sciences OÜ 201705 Managing Director + Exosomics Siena SpA 201705 CEO) |
Managing Director |
Lonza (Group) |
Estonia |
Chiesi, Paolo (Chiesi 201309 VP + RnD Director) |
Research & Development Manager |
Chiesi (Group) |
Italy |
Chiha, Slim (Prosion 202308 Managing Director (CEO) + Co-Founder) |
Chief Executive Officer (CEO) |
Prosion GmbH (Prosion Therapeutics) |
Germany |
Chilian, Bruno (TRI Thinking Research Instruments 202205 Managing Partner) |
Managing Partner |
TRI Thinking Research Instruments GmbH |
Germany |
Chiriano, Gianpaolo (Mirabaud 202209 Managing Director) |
Managing Director |
Mirabaud Bank |
Switzerland |
Chiswell, David (Kymab 201604–201904 CEO before interim CEO since early 2015 before Nabriva + Albireo + CAT + Amersham) |
Chief Executive Officer (CEO) |
Sanofi (Group) [since May 2011] |
United Kingdom (GB) |
Chiu, Michael (Erbi Biosystems 2022 CEO joined 2018 as COO) |
Chief Executive Officer (CEO) |
Merck (DE) (Group) |
United States (USA) |
Chiva, Cristina (Centre for Genomic Regulation CRG 201201 Acting Manager of CRG/UPF Proteomics Unit) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
Centre for Genomic Regulation (CRG) (Spain) |
Spain (España) |
Cho, Jeong-Woo (SK Group 201902 CEO of SK Biopharmaceuticals) |
Chief Executive Officer (CEO) |
SK Group (Group) |
Korea, Republic of |
Cho, Sung Hee (FCB-Pharmicell 201010– Managing Director of Pharmicell Europe GmbH) |
Managing Director |
RNL Bio (Group) |
Germany |
Chornet, Nicolas (Moderna 202009 SVP International Manufacturing Europe) |
Production Manager |
Moderna (Group) |
Switzerland |
Choudhary, Asheesh (Cargill 202105 Global Business Development Director Bioindustrial) |
Business Development Manager / Strategy Manager |
Cargill (Group) |
United States (USA) |
Choulika, André (Cellectis 200701 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Cellectis (Group) |
France |
Choveaux, David (Sparta Biodiscovery 202309 Business Development + Operations) |
Business Development Manager / Strategy Manager |
Sparta Biodiscovery Ltd. |
|
Chow, Hong (Merck (DE) 202110– Head of China + International for Healthcare before Roche + Bayer/Schering) |
Regional manager |
Merck (DE) (Group) |
Germany |
Chowrira, Bharatt (PureTech Health 202404– promoted to CEO before Synlogic + Auspex + Addex + Nektar) |
Business Development Manager / Strategy Manager |
PureTech Health (Group) |
United Kingdom (GB) |
Chrintz, Ole (Lundbeck 201304 SVP International Markets + Europe) |
President/Director/Head Business Group/Unit/Division |
Lundbeck (Group) |
Denmark |
Chrisman, Anna (Informa 201511 Managing Director at EBD Group) |
Managing Director |
Informa (Group) [NEW] |
United States (USA) |
Christ, Arnd (Immatics 202010– CFO before InflaRx + Proteros + MediGene + NovImmune + Probiodrug + Hoechst) |
Chief Financial Officer (CFO) |
Immatics (Group) |
Netherlands |
Christ, Joachim (Merck (DE) 201704– Chief Procurement Officer before Head of Group Controlling) |
management (personnel) |
Merck (DE) (Group) |
Germany |
Christel, Luca Pascal (Apoly GmbH 201601 Managing Director) |
Managing Director |
Apoly GmbH |
Germany |
Christély, Thomas (MetrioPharm 202108– CEO before MYR GmbH + Atugen AG) |
Chief Executive Officer (CEO) |
MetrioPharm (Group) |
Switzerland |
Christgau, Stephan (Eir Ventures 202007– Founding Partner before Novo Seeds + Osteologix) |
Partner (venture partner) |
Eir Ventures (Group) |
Sweden |